Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Roche, FDA and Susvimo
Roche gains label expansion for eye implant Susvimo to treat diabetic macular edema
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema (DME), which is the leading cause of diabetes-related blindness.
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)With as few as two treatments per year, Susvimo may help people with DME maintain their visionApproval marks the second indication for Susvimo in addition to neovascular or ‘wet’ age-related macular degeneration (nAMD) Basel,
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
Roche announces FDA approves Susvimo to treat DME
Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a
Roche's Susvimo gets FDA approval for diabetic macular edema
Genentech unit has received FDA approval for its drug Susvimo 100 mg/mL injection for the treatment of diabetic macular edema, a leading cause of blindness for people with diabetes. Susvimo, also known as ranibizumab injection,
FDA approves continuous delivery ranibizumab injection (Susvimo) for the treatment of diabetic macular edema
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a one-time, outpatient procedure, continuously delivering a customized formulation of ranibizumab over time.
Genentech : FDA Approves Susvimo For Diabetic Macular Edema Treatment
Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susv
Roche: FDA Approves Susvimo for Treatment of Diabetic Macular Edema
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech initially won Food and Drug Administration approval of the refillable implant in 2021 for patients with we
pharmaphorum
2y
FDA clears Roche's Susvimo implant for eye disease wet AMD
Susvimo
has the same active ingredient as
Roche
's big-selling therapy Lucentis (ranibizumab), a VEGF inhibitor administered once a month that has been approved by the FDA since 2006 for wet AMD.
GlobalData on MSN
3mon
Siloton secures £860k to advance eye imaging chip for AMD
Meanwhile,
Roche
has relaunched
Susvimo
(ranibizumab injection) for use as an ocular implant for the treatment of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Places global staff on leave
Suspends parcels from China
Wins Senate committee vote
Senate confirms Bondi as AG
Plans to take over Gaza
RFK Jr. clears Senate panel
Arrested on multiple charges
Offers to jail US criminals
EPA warns employees
Sued by former nanny
Sued for discrimination
To launch streaming service
FBI agents sue DOJ
Mimics moon’s gravity
US job openings fall
Key Bridge design unveiled
US begins migrant flights
Adds surcharge to eggs
Neo-Nazi leader convicted
Confirmed as VA secretary
To cut up to 7,000 jobs
Sweden school shooting
DOJ to battle antisemitism
Baby elephant at OR Zoo
Announces death of mother
Atmospheric river slams CA
Suspended 10 games
Spiritual leader dies
Feedback